Ann: SIRFLOX ASCO Abstract Released, page-19

I don't really see anything new being released today really. Sir spheres are a brilliant tool, but I expect that the trajectory of doses will remain at a similar level of growth based on this info.

Overall survival is the key to radically increasing doses sold. We already knew that the PFS data is good.

Also the growth rate at 6 months over last year was 26% versus pcp. Now it has diminished slightly to 22% for ten months.

So I did the only smart thing and shorted it once the steam was let out today. Good luck to all. I look forward to longing SRX again soon.